Abstract Details
|
Eduardo Nobile-Orazio, MD, PhD, FAAN
(Milan University, IRCCS Humanitas Clinical Institute)
PRESENTER |
Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire. |
| No disclosure on file | |
| Stefano Jann, MD | No disclosure on file |
| Antonino Uncini, MD (Dept of Neuro Neuroscience Clinic Neuro) | No disclosure on file |
| John G. Whitesides | John G. Whitesides has received personal compensation for serving as an employee of UCB. John G. Whitesides has received stock or an ownership interest from UCB. |
| No disclosure on file | |
| Ettore Beghi, MD, FAAN | No disclosure on file |
| Giovanni Antonini | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Angelo Schenone (Univ of Genova) | No disclosure on file |
| Ada Francia, MD (Policlinico Umberto I) | No disclosure on file |
| Davide Pareyson, MD (Fondazione IRCCS Istituto Neurologico Carlo Besta) | No disclosure on file |
| Lucio Santoro | No disclosure on file |
| Stefano Tamburin | No disclosure on file |
| Guido Cavaletti | No disclosure on file |
| No disclosure on file | |
| No disclosure on file |